AR016200A1 - El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicion - Google Patents
El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicionInfo
- Publication number
- AR016200A1 AR016200A1 ARP990101431A ARP990101431A AR016200A1 AR 016200 A1 AR016200 A1 AR 016200A1 AR P990101431 A ARP990101431 A AR P990101431A AR P990101431 A ARP990101431 A AR P990101431A AR 016200 A1 AR016200 A1 AR 016200A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- permeability
- kit
- manufacture
- increase
- Prior art date
Links
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000035699 permeability Effects 0.000 title abstract 3
- 229910052717 sulfur Inorganic materials 0.000 title abstract 3
- 239000011593 sulfur Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 240000008042 Zea mays Species 0.000 title 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 title 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 title 1
- 235000005822 corn Nutrition 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
El uso de una composicion que comprende uno o más compuestos que contienen azufre para la fabricacion de un medicamento util para aumentar la permeabilidaddel tejido corneo humano a los agentes activos, caracterizado porque consiste en una cantidad efectiva de uno o más compuestos que contienen azufre al tejidocorneo humano durante un período de tiempo suficiente para aumentar la permeabilidad del tejido corneo humano a los agentes activos, y un kit que incluye dichacomposicion.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8021298P | 1998-03-31 | 1998-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016200A1 true AR016200A1 (es) | 2001-06-20 |
Family
ID=22155965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101431A AR016200A1 (es) | 1998-03-31 | 1999-03-30 | El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicion |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR016200A1 (es) |
| AU (1) | AU3212099A (es) |
| CO (1) | CO5070608A1 (es) |
| WO (1) | WO1999049895A2 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6932861B2 (en) | 2000-11-28 | 2005-08-23 | Fmc Corporation | Edible PGA coating composition |
| GB0103046D0 (en) | 2001-02-07 | 2001-03-21 | Novartis Ag | Organic Compounds |
| GB0511499D0 (en) * | 2005-06-06 | 2005-07-13 | Medpharm Ltd | Topical ungual formulations |
| ATE444071T1 (de) * | 2006-08-17 | 2009-10-15 | Klever Mode S L | Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen |
| WO2011155887A1 (en) * | 2010-06-07 | 2011-12-15 | Topical Pharma Ab | Kit for the treatment of onychomycosis by nitric oxide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4956467A (en) * | 1988-04-01 | 1990-09-11 | American Cyanamid Company | Nucleophilic tertiary organophosphines |
| IL97012A0 (en) * | 1990-01-30 | 1992-03-29 | Gist Brocades Nv | Topical preparations for treating human nails |
| IT1249047B (it) * | 1991-02-21 | 1995-02-11 | Zambon Spa | Composizione farmaceutica per il trattamento della cataratta |
| FR2681782B1 (fr) * | 1991-09-26 | 1993-12-17 | Oreal | Composition pour le traitement des ongles contenant un aminoacide soufre. |
| US5696164A (en) * | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
-
1999
- 1999-03-29 WO PCT/US1999/006743 patent/WO1999049895A2/en not_active Ceased
- 1999-03-29 AU AU32120/99A patent/AU3212099A/en not_active Abandoned
- 1999-03-30 AR ARP990101431A patent/AR016200A1/es unknown
- 1999-03-30 CO CO99019173A patent/CO5070608A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3212099A (en) | 1999-10-18 |
| WO1999049895A2 (en) | 1999-10-07 |
| WO1999049895A3 (en) | 1999-11-18 |
| CO5070608A1 (es) | 2001-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2183186T3 (es) | Composiciones cosmeticas en polvo que contienen elastomeros de silicona. | |
| KR920019342A (ko) | 골질환 치료제 | |
| DE60117043D1 (de) | Behandlung von mukositis | |
| BR0009830A (pt) | Composições para cuidados com a pele contendo uma combinação de substâncias ativas para cuidados com a pele | |
| NZ597106A (en) | Ophthalmic compositions comprising carnitine and methods for treating eyes | |
| ES2058291T3 (es) | Derivados de piperazinilo de las purinas e isosteros de las mismas como agentes hipoglucemicos. | |
| AR018286A1 (es) | Composicion farmaceutica que en calidad de principio activo contiene la asociacion de metformina y fibrato, y la utilizacion de esta asociacion para preparar medicamentos | |
| BRPI0017528B8 (pt) | uso de uma composição contendo sal de cetotifeno | |
| MX9602806A (es) | Derivados del 1,2,4-oxadiazol y su uso como parasiticidas para animales. | |
| ES2044840T3 (es) | Composiciones estabilizadas del activador del plasminogeno de tejido humano. | |
| ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| CO5001019A1 (es) | Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales | |
| ES2011232T3 (es) | Composiciones farmaceuticas de piroxicam en soluciones acuosas y procedimiento para su preparacion. | |
| BR0304298A (pt) | Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume | |
| BR0015392A (pt) | Lipoxina a4 e seus análogos para o tratamento de olho ressecado | |
| BR9814299A (pt) | Aminobiguanidas e o seu uso para desinfetarlentes de contato e preservar composiçõesfarmacêuticas | |
| ES2125469T3 (es) | Articulos absorbentes con componentes de cubricion de ropa interior predispuestos a envolver automaticamente los lados de prendas interiores. | |
| ES2125734T3 (es) | Utilizacion de un 2-amino-alcano-1,3-diol para frenar la caida de los cabellos y/o inducir y estimular su crecimiento. | |
| DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
| PT1001775E (pt) | Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil | |
| AR016200A1 (es) | El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicion | |
| AR004077A1 (es) | Una composicion particularmente cosmetica, y mas particularmente para la deformacion permanente de las fibras queratinicas. | |
| SE7512231L (sv) | Steriliseringsmedel | |
| ES2118726T3 (es) | Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos. | |
| BR0016637A (pt) | Agente para o combate de parasitas/depsipeptìdeo |